1. Home
  2. NXST vs BLTE Comparison

NXST vs BLTE Comparison

Compare NXST & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexstar Media Group Inc.

NXST

Nexstar Media Group Inc.

N/A

Current Price

$186.48

Market Cap

5.4B

Sector

Industrials

ML Signal

N/A

Logo Belite Bio Inc

BLTE

Belite Bio Inc

N/A

Current Price

$156.69

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NXST
BLTE
Founded
1996
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.0B
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
NXST
BLTE
Price
$186.48
$156.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
7
Target Price
$263.75
$198.00
AVG Volume (30 Days)
378.4K
151.0K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
3.67%
N/A
EPS Growth
N/A
N/A
EPS
5.09
N/A
Revenue
$4,949,000,000.00
N/A
Revenue This Year
$11.38
N/A
Revenue Next Year
N/A
$492.11
P/E Ratio
$36.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$154.47
$60.00
52 Week High
$254.30
$200.00

Technical Indicators

Market Signals
Indicator
NXST
BLTE
Relative Strength Index (RSI) 59.96 55.25
Support Level $177.36 $146.18
Resistance Level $191.30 $160.48
Average True Range (ATR) 6.10 6.37
MACD 0.95 0.40
Stochastic Oscillator 72.64 67.93

Price Performance

Historical Comparison
NXST
BLTE

About NXST Nexstar Media Group Inc.

Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Assuming its merger with Tegna is affirmed Nexstar's station total would exceed 259 and reach 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: